000 01269 a2200373 4500
005 20250518035039.0
264 0 _c20191203
008 201912s 0 0 fre d
022 _a2542-4513
024 7 _a10.1016/j.jdmv.2019.02.004
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrikha, F
245 0 0 _a[Tocilizumab for refractory Takayasu arteritis with aortic aneurysm].
_h[electronic resource]
260 _bJournal de medecine vasculaire
_cMay 2019
300 _a237-239 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAnti-Inflammatory Agents
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aAortic Aneurysm
_xdiagnostic imaging
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aRemission Induction
650 0 4 _aTakayasu Arteritis
_xcomplications
650 0 4 _aTreatment Outcome
700 1 _aGarbaa, S
700 1 _aBouattour, Y
700 1 _aSnoussi, M
700 1 _aLoukil, H
700 1 _aBen Salah, R
700 1 _aBahloul, Z
773 0 _tJournal de medecine vasculaire
_gvol. 44
_gno. 3
_gp. 237-239
856 4 0 _uhttps://doi.org/10.1016/j.jdmv.2019.02.004
_zAvailable from publisher's website
999 _c29631967
_d29631967